![ESMO-Deep-Dive-Upper-Digestive-Cancers-1000x250-Hepatocellular-Cancer](/var/esmo/storage/images/media/esmo/meetings/2022/_webinars/webinar-series/deep-dive/esmo-deep-dive-upper-digestive-cancers-1000x250-hepatocellular-cancer/9851689-3-eng-GB/esmo-deep-dive-upper-digestive-cancers-1000x250-hepatocellular-cancer_i770.jpg)
ESMO Members: Take the CME test
and receive 2 ESMO - MORA point
Learning objectives:
- To inform on state-of-the-art strategies for treating intermediate-stage HCC patients
- To provide insights on optimal first-line systemic and locoregional therapy options
- To highlight ongoing research on second line and beyond systemic therapy for HCC